We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.38B
AUM Growth
+$356M
Cap. Flow
-$95.3M
Cap. Flow %
-1.77%
Top 10 Hldgs %
22.08%
Holding
225
New
6
Increased
74
Reduced
113
Closed
13

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$41.5M
2
SLB icon
SLB Ltd
SLB
+$19.4M
3
GSK icon
GSK
GSK
+$15.1M
4
EOG icon
EOG Resources
EOG
+$10.5M
5
APA icon
APA Corp
APA
+$9M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$80.1M
2
CELG
Celgene Corp
CELG
+$72.6M
3
BWA icon
BorgWarner
BWA
+$26.4M
4
EXPE icon
Expedia Group
EXPE
+$26.1M
5
XRAY icon
Dentsply Sirona
XRAY
+$19.3M

Sector Composition

Rank Sector Weight
1 Financials 23.04%
2 Technology 14.53%
3 Industrials 13.46%
4 Healthcare 13.02%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
151
Eli Lilly
LLY
$1.06T
$745K 0.01%
5,672
+200
+4% +$23.2K
BDX icon
152
Becton Dickinson
BDX
$48.8B
$740K 0.01%
2,789
-106
-4% -$26.4K
NKE icon
153
Nike
NKE
$62.3B
$703K 0.01%
6,942
+55
+0.8% +$5.18K
MTB icon
154
M&T Bank
MTB
$36.1B
$668K 0.01%
3,933
-200
-5% -$32.5K
AKAM icon
155
Akamai
AKAM
$17.2B
$587K 0.01%
6,800
-597
-8% -$52.2K
EMR icon
156
Emerson Electric
EMR
$87.5B
$575K 0.01%
7,540
-683
-8% -$49.2K
EPD icon
157
Enterprise Products Partners
EPD
$82.3B
$575K 0.01%
20,411
-994
-5% -$26.9K
WM icon
158
Waste Management
WM
$91.5B
$563K 0.01%
4,936
-385
-7% -$43.5K
MCHP icon
159
Microchip Technology
MCHP
$40.4B
$560K 0.01%
10,696
– –
KKR icon
160
KKR & Co
KKR
$92.8B
$559K 0.01%
19,171
– –
MDT icon
161
Medtronic
MDT
$110B
$531K 0.01%
4,677
+131
+3% +$14.4K
UPS icon
162
United Parcel Service
UPS
$87.7B
$516K 0.01%
4,409
-1,260
-22% -$149K
PLD icon
163
Prologis
PLD
$130B
$496K 0.01%
5,563
+65
+1% +$5.76K
DELL icon
164
Dell
DELL
$283B
$484K 0.01%
18,580
-3,614
-16% -$94K
AZO icon
165
AutoZone
AZO
$50.1B
$482K 0.01%
405
– –
PM icon
166
Philip Morris
PM
$293B
$474K 0.01%
5,576
-814
-13% -$67.1K
TGT icon
167
Target
TGT
$66.8B
$473K 0.01%
3,689
+302
+9% +$35.4K
LIN icon
168
Linde
LIN
$226B
$439K 0.01%
2,062
-4,065
-66% -$819K
ED icon
169
Consolidated Edison
ED
$40.2B
$423K 0.01%
4,676
– –
KMB icon
170
Kimberly-Clark
KMB
$36.1B
$413K 0.01%
3,006
-508
-14% -$68.7K
SYK icon
171
Stryker
SYK
$129B
$411K 0.01%
1,960
+220
+13% +$45.7K
NVO
172
Novo Nordisk
NVO
$203B
$383K 0.01%
13,220
+420
+3% +$11.6K
PAYX icon
173
Paychex
PAYX
$42.7B
$374K 0.01%
4,392
-14
-0.3% -$1.18K
MNST icon
174
Monster Beverage
MNST
$92.1B
$356K 0.01%
11,192
-1,000
-8% -$29.4K
DUK icon
175
Duke Energy
DUK
$96.6B
$340K 0.01%
3,732
-529
-12% -$48.5K
5 6
7
8 9

Similar funds

BIM
Bridges Investment Management Omaha, Nebraska $7.38B AUM 15.39% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Douglas Lane & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Douglas Lane & Associates held 225 positions worth $5.38B, up 7.1% from $5.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas Lane & Associates's Q4 2019 filing shows 6 new, 74 increased, 113 reduced and 13 closed positions. Its largest new stake was Elanco Animal Health: 120,472 shares worth $3.55M. The largest sale was People Inc, an estimated $80.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Douglas Lane & Associates's largest Q4 2019 buy was Elanco Animal Health: 120,472 shares worth $3.55M.
  • Douglas Lane & Associates added most to Bristol-Myers Squibb in Q4 2019, an estimated $41.5M increase.
  • Douglas Lane & Associates's biggest Q4 2019 reduction was People Inc, cutting an estimated $80.1M.
  • Douglas Lane & Associates fully exited Celgene Corp in Q4 2019, selling an estimated $72.6M.
  • Douglas Lane & Associates's ten largest holdings make up 22% of its $5.38B portfolio in Q4 2019.
  • Douglas Lane & Associates opened 6 new positions and closed 13 in Q4 2019.
  • Douglas Lane & Associates's portfolio value rose 7.1% quarter-over-quarter to $5.38B.

Based on Douglas Lane & Associates's 13F filing for Q4 2019, filed 27 Jan 2020.